Evelo Biosciences's market cap is currently $47.46K. The company's EPS TTM is $-13.35; its P/E ratio is ―; Evelo Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -108.47M	$ -115.40M	$ -91.89M	$ -86.36M	$ -58.10M
EBITDA	$ -106.34M	$ -115.40M	$ -91.89M	$ -86.36M	$ -58.10M
Net Income	$ -114.53M	$ -122.18M	$ -93.67M	$ -85.66M	$ -53.85M
Balance Sheet
Cash & Short-Term Investments	$ 47.94M	$ 68.44M	$ 68.86M	$ 77.83M	$ 147.92M
Total Assets	$ 64.44M	$ 87.87M	$ 90.64M	$ 90.92M	$ 159.87M
Total Debt	$ 51.14M	$ 56.29M	$ 40.04M	$ 19.63M	$ 12.30M
Net Debt	$ 3.20M	$ -12.15M	$ -28.82M	$ -58.20M	$ -135.61M
Total Liabilities	$ 69.43M	$ 79.20M	$ 60.15M	$ 30.72M	$ 22.92M
Stockholders' Equity	$ -4.99M	$ 8.67M	$ 30.48M	$ 60.20M	$ 136.95M
Cash Flow
Free Cash Flow	$ -101.86M	$ -98.24M	$ -74.38M	$ -75.01M	$ -52.74M
Operating Cash Flow	$ -101.23M	$ -96.72M	$ -73.06M	$ -71.98M	$ -47.28M
Investing Cash Flow	$ -622.00K	$ -1.48M	$ -1.31M	$ 51.97M	$ -60.13M
Financing Cash Flow	$ 81.66M	$ 97.54M	$ 65.47M	$ 4.99M	$ 162.01M

Currency in USD

Evelo Biosciences Earnings and Revenue History

Income Statement >

Evelo Biosciences Debt to Assets

Balance Sheet >

Evelo Biosciences Cash Flow

Cash Flow >

Evelo Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing